Researchers at the Indian Institute of Technology Bombay have developed a gentler method to recover lab-grown T-cells, a crucial step in CAR T-cell therapy. Using the mild enzyme Accutase instead of harsher alternatives helps improve cell survival and preserve immune function. The approach enhances the reliability and efficiency of immunotherapy production, supports cost reduction, and strengthens India’s efforts to make advanced cancer treatments more affordable and accessible.
Click to View MoreIndia must treat mental health as a national priority, not a side issue. By strengthening primary care, integrating support across sectors, using technology, and reducing stigma, India can turn silent suffering into shared strength—empowering citizens, enabling inclusion, and securing a healthier, more resilient foundation for its future development.
Click to View More
© 2026 iasgyan. All right reserved